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(E.K. Sinner).The topic synthetic biology appears still as an ‘empty basket to be ﬁlled’. However, there is already
plenty of claims and visions, as well as convincing research strategies about the theme of synthetic
biology. First of all, synthetic biology seems to be about the engineering of biology – about bottom-
up and top-down approaches, compromising complexity versus stability of artiﬁcial architectures,
relevant in biology. Synthetic biology accounts for heterogeneous approaches towards minimal
and even artiﬁcial life, the engineering of biochemical pathways on the organismic level, the mod-
elling of molecular processes and ﬁnally, the combination of synthetic with nature-derived materi-
als and architectural concepts, such as a cellular membrane. Still, synthetic biology is a discipline,
which embraces interdisciplinary attempts in order to have a profound, scientiﬁc base to enable
the re-design of nature and to compose architectures and processes with man-made matter.
We like to give an overview about the developments in the ﬁeld of synthetic biology, regarding
polymer-based analogs of cellular membranes and what questions can be answered by applying
synthetic polymer science towards the smallest unit in life, namely a cell.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction Concerning some aspects of synthetic biology, a question mayBiological systems, from unicellular prokaryotic forms like yeast
or bacteria to highly developed multicellular organisms, are com-
plex in their structural–functional organization. All forms of life
are based on cells – the smallest units, exhibiting structure and
functional organization, which are certain properties of life.
Generally, it is believed that understanding the structure, func-
tion, and the dynamics of cells at molecular level will be the key
toward the answers of fundamental questions regarding the deﬁni-
tion and the origin of life. Over the years, the fascination of the life
science researchers has been gradually expanded from studying
the functional complexity of cells from phenomenological descrip-
tion to ‘‘functional’’ approaches. Recently, this concept turned out
to be an ultimate subject of synthetic biology. Generally speaking
synthetic biology is concerned with the design and synthesis of
chemical structures such as enzymes, proteins, genetics circuits
and cells, which do not exist in nature as such. One of the novel
aims of synthetic biology is the redesign of well-known biological
systems. In other words, the hybrid discipline of synthetic biology
aims at understanding, re-composition as well as constructing
architectures of life.al Societies. Published by Elsevier
ova), nallanim@imre.a-star.-
eier), eva.sinner@boku.ac.atarise where the border between biomimetic chemistry and syn-
thetic biology is. Here it is important to mention, that biomimetic
chemistry exploits organic synthesis to generate artiﬁcial mole-
cules that mimic natural molecules such as enzymes for instance.
Indeed, mimicking does not mean reproducing life. Hence, syn-
thetic biology comprises biomimetic chemistry and emerges as a
novel, sophisticated topic in the ﬁeld of evolving sciences.
In fact, many scientists are skeptical about calling synthetic
biology a new ﬁeld. Some materials or concepts are not even newly
invented as they had been explored in other contexts long time ago
(e.g., synthetic amino acids, modiﬁcation of nucleic bases), but ap-
pear now in combination with newly developed characterization
methods worthwhile to be re-investigated in the dimension of sin-
gle molecule interactions. Apparently, the fundament of the term
synthetic biology is expanding toward a concerted and integrative
development of the diverse disciplines such as Chemistry, Biology,
Physics, Material Science, Engineering, Medicine and the Pharma-
ceutical Industry with process development and integration.
2. Evolving ﬁelds to be ‘‘under the umbrella’’ of synthetic
biology
Synthetic biology addresses novel approaches to build artiﬁcial
cells; one is described as a top down approach and the second one
is known as a bottom up approach. The ﬁrst approach is directed
toward the elimination of cellular components that are interpretedB.V. Open access under CC BY-NC-ND license.
Fig. 2. Schematic representation of a ‘‘semi-synthetic minimal cell’’ as deﬁned by
Luisi and coworkers. Printed depending on permission from Elsevier.
V. Malinova et al. / FEBS Letters 586 (2012) 2146–2156 2147to be non-essential for a cell to be alive. This, respectively, has led
to the search for a minimal genome needed for a cell to function.
Estimation based on mapping out all of the genes involved in the
DNA transcription and translation, protein biosynthesis, and lipid
metabolism reveals that 150 genes are about the minimal number
[1]. This type of minimal cells results from bioengineering of exist-
ing cells, and therefore these experiments are envisaged as in vivo
synthetic biology [2]. Additionally, following this concept, a mini-
mal genome with genes of interest can be introduced in a host cell
(e.g. transforming bacterial cell in a cell-bioreactor to produce bio-
fuels or any molecules of interest). Upon cell division, newly syn-
thetic cells are thus formed. A pragmatic implementation of the
genome transplantation approach has been demonstrated by Craig
Ventor’s laboratory [3].
The second approach can be described as bottom-up approach
and is concerned with the design and construction of a cell proto-
type. It can be else subsumed as ‘‘proto-cell approach’’, embedding
synthetic molecules, labeled molecules, or even functional com-
plexes, aiming for a ‘‘modiﬁed or even artiﬁcial cell’’. The strategies
involved in the bottom-up construction of a proto-cell or even sim-
pler architectures for sensing and actuating can be described as
compromise between the smallest unit of life (the cell) and single
molecular assemblies (Fig. 1).
Compared with the synthetic genomics approach, which is
based on forcing the natural cell to follow the instructions encoded
by the introduced synthetic genome, the proto-cell approach goes
a different route towards a fully artiﬁcial organism, where the
composites, not only the genome, but also all building blocks of a
cell, eventually are generated in vitro. It is important here to indi-
cate that the terms ‘‘minimal cell’’ and ‘‘artiﬁcial cell’’ are used in
literature interchangeably, but do not necessarily mean the same
thing. A minimal cell has a minimal, but sufﬁcient set of properties
to be called living; these are self-maintenance, self-reproduction
and ability to evolve (Fig. 2). A synthetic cell, made from artiﬁcial
components is not necessarily designed to be alive or ‘‘minimal’’
in its outset, but for instance to be more robust (mechanically) toFig. 1. Cartoon, visualizing the underlying oxymoron in bio-oriented science:
aiming at the most relevant ‘‘synthetic’’ Bio-architecture (the living cell), which,
intrinsically, provides the highest complexity and linked with this feature –
maximal drawbacks in reproducibility.be used for biotechnical and biomedical applications. Despite the
different names (i.e. protocell, artiﬁcial cell, minimal cell, synthetic
cell, or semi-synthetic cell) used in literature, all these structures
are uniﬁed by a common feature, namely all being chemical micro-
compartments, organized at structural and functional level, dis-
playing cell-like behavior, such as proliferation, differentiation
and ampliﬁcation.
In the last couple of years, lipid vesicles (liposomes) are consid-
ered as suitable compartments and most likely as precursors of a
‘‘minimal cell’’, which allow encapsulation of the molecules of live
(proteins, enzymes, DNA, RNA) and allow compartmentalized, bio-
chemical reactions. The reasons for this are simple:
(1) the boundary of a lipid vesicle is a bilayer of amphiphilic
lipid molecules analogous to the lipid membrane of a natural
cell;
(2) there are established methods for the preparation of lipid
vesicles with sizes comparable to the cellular sizes;
(3) lipid vesicles can undergo shape changes, budding and ﬁs-
sion, similar to biological cells [4,5]. It is, therefore, conve-
nient to use lipid vesicles as cell-mimicking containers for
carrying out more and more sophisticated reactions resem-
bling the biochemical pathways of a cell in synthetic, inte-
grated, functional molecular complexes.
There are already numerous attempts on complex biochemical
reactions inside lipid vesicles summarized in several reviews [6–
12]. The scientiﬁc strategies involved in can be categorized as
follows:
(1) synthesis of an oligonucleotide (polyA from ADP by the
enzyme PNPase) [13,14], moreover the polyA synthesis
was demonstrated to be compatible with vesicle reproduc-
tion [15].
(2) RNA [16–19] and DNA [20] replication;
(3) DNA ampliﬁcation with the polymerase chain reaction [21];
(4) mRNA translation [22], RNA synthesis and cellular delivery,
DNA elongation [23] and DNA transcription [24,25];
(5) autocatalytic sugar synthesis (formose reaction) inside lipid
vesicles [26].
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tein expression inside lipid vesicles [27–29,19,30–37], The mini-
mal size of liposome-based model cells brings about a
remarkably enhanced entrapment and protein synthesis. So far
most research has been conducted with green ﬂuorescent protein
(GFP) as a convenient model protein to allow facile detection of
the protein expression with a confocal microscope. A remarkable
protein expression in a liposomal system was reported by Murtas
et al. [34] who used a well-deﬁned, cell-free minimal protein syn-
thesis set, composed of 36 enzymes, 70S ribosomes, tRNAs, and
cofactors (Pure Systems), which was co-encapsulated with a plas-
mid, coding for enhanced GFP (eGFP). Furthermore, an controllable
membrane permeability [38] and more efﬁcient nutrient uptake
have been investigated by co-expression of a pore-forming protein
in the liposomal membrane. As a result eGFP expression inside the
vesicle could be continued for up to several days since energy and
nutrients could be transported from the outside into the vesicular
compartment [39–41].
A second fundamental milestone to achieve with the liposome-
model is to represent the ability of any living cell to self-reproduce.
The growth and the self-reproduction process of lipid vesicles were
recently reviewed by Stano and Luisi [12]. Mainly two approaches
for triggering vesicle reproduction are proposed in literature: the
ﬁrst approach is implemented by addition of fatty acid precursor
(the corresponding anhydrides of the fatty acid) solution to vesi-
cles, hydrolysis of the precursor resulted in the formation of extra
fatty acid and therefore in the growth of the vesicle [42–45]. The
second approach relies on the encapsulation of Fatty Acid Synthe-
tase (FAS) enzyme in lipid vesicles for the synthesis of fatty acids
and their incorporation into the lipid bilayer [46–48].
Nature has chosen the membrane as the primary structure for
encapsulation and compartmentalization of biological molecules
and systems. Scientists, however, suggested that two-dimensional
segregation of molecules on surfaces might be the simplest way to
establish modular systems [49]. Hence, a solid-supported mem-
brane system where an intact lipid bilayer is formed on solid sur-
faces has been reported to be a particularly successful model for
thorough biophysical characterization with modern biophysical
techniques [50,51] and became an interesting architecture for the-
oretical analysis [52]. Due to a thin aqueous layer beneath the
respective planar surface, it is usually assumed that the lipids
can diffuse in the two-dimensional liquid structure of the tethered
membrane and, as such, remain relatively unaffected by the sur-
face. Nevertheless, the solid-supported membrane-like architec-
ture is not yet an optimal model in the ﬁeld of tethered
membranes as often the lateral mobility of the inserted membrane
proteins has been considered as irrelevant to enable their full func-
tionality (e.g., ion channel). Taken together, the reconstitution of
integral membrane proteins into planar supported membrane
architectures will probably in future evolve towards more syn-
thetic architectures, where hydrogels or other polymer cushions
will be employed to synthesize, stabilize and even protect planar
tethered membrane architectures on solid supports [51,53,54].
The biggest advantage of the supported membrane system is its
adaptability to a large number of biophysical characterization
techniques. Optical microscopy and spectroscopy techniques are
easily applicable, but (stabilized) membranes are also suitable for
scanning probe microscopy. Impedance measurements such as
quartz crystal microbalance and surface plasmon resonance
[55,56] as well as total internal reﬂection ﬂuorescence to observe
single molecules [57,58] as alternative methods for ultra-fast mea-
surements of proteins in solid supported membranes are also
underway [59]. Consequently, the micro and nanostructure of sup-
ported membranes with- or without integral proteins can be char-
acterized with high spatiotemporal precision, such, for instance, isprovided by transmission electron microscopy (TEM) imaging of
outer membrane protein structures (e.g., S-layer protein assem-
blies) [60,61]. Even integrated protein crystals, such as rhodopsin
molecules building the purple membrane patches can be reconsti-
tuted and investigated by atomic force microscopy (AFM) [62,63],
which is known to be an invasive method for soft matter analysis.
Hence, AFM technique shows a great potential to explore diverse,
functional, single proteins [64–66]. AFM is able to resolve atomic
details on the external domains of transmembrane proteins
[62,67] and to ‘‘feed’’ data into the theoretical analysis of molecular
interactions in biology [68].
However, closed structures made of lipid bilayers (giant unila-
mellar vesicles, GUVs) comprise a complementing approach to
study cellular membranes. Due to their gigantic dimensions com-
pared to the world of ‘‘nano’’ (from several micrometers up to hun-
dreds of micrometers) and large unperturbed areas, the vesicular
membranes are perfectly compatible with optical methods such
as light and ﬂuorescence microscopy and provide membrane areas,
which behave uncoupled from any surface forces. The most popu-
lar microscope-based techniques for investigation of dynamic pro-
cesses in lipid membranes have been reviewed recently [69].
To date, a lot of research is being focused on lipid vesicles as a
versatile platform for reproducing of cellular processes and model-
ing of artiﬁcial cells. The use of lipids as building blocks of artiﬁcial
cells is reasonable as they are constructive elements of most bio-
logical cells. Lipids impart to synthetic membranes biocompatibil-
ity and permeability, important criteria for the integrity of a
synthetic cell. However, intrinsic drawbacks of the lipid vesicle
model such as mechanical and chemical instability, short circula-
tion lifetime and uncontrollable interaction with lipoproteins af-
fect their compatibility with engineering approaches and with
important analytical methods such as NMR, AFM and TEM/SEM.
Polymer science addresses effectively these drawbacks and en-
ables a programmed control over chemical structure and physical
properties. Hence, many recent studies are focused on polymer-
based artiﬁcial organelles and nanocompartments as synthetic
analogs of liposomes. In general case, these might be dendrimer-
like structures, layer-by-layer capsules (LBL) or block copolymer
vesicles (polymersomes). [70].
In the following section we will review the use of polymer-
based architectures as a novel platform for protein insertion and
characterization, the engineering of artiﬁcial organelles and the
perspective of creating cell-mimicking models.
Polymersomes consist of a polymeric membrane with an insol-
uble middle and a soluble outer layer, similar in this respect to the
bilayer architecture of a phospholipid membrane. Polymersomes
are generally built from amphiphilic block copolymers of AB, ABA
or ABC type. In contact with water these polymers undergo a
microphase separation and self-aggregate spontaneously to form
vesicles, encapsulating aqueous medium. However, they are much
stable towards organic solvents and even stable in air, which is a
critical advantage over lipid-based architectures.
Polymersome-formation and structure are quite similar to
liposomes, which make them very popular in the artiﬁcial orga-
nelle community as being currently the second model of cellular
mimics besides liposomes. The principle idea of using synthetic
molecules stabilizing cell membrane mimetic architectures had
been evolved by Helmut Ringsdorf [71]. The groups of Discher
and Nolte were among the ﬁrst exploring complex synthetic
bio-inspired architectures [72–75]. Artiﬁcial bio-membranes are
the research ﬁeld, which arose 20 years ago and since then many
aspects and methods were addressed [76–80]. Today, there are
various activities and researcher’s names, related with the design
principles and with the existing library of suitable polymeric
materials [81–84].
Fig. 3. Illustration of selective access to PMOXA-b-PDMS-b-PMOXA polymersomes.
(A) The membrane itself shows permeability to a small number of molecules only.
(B and C) Selective access into and egress out of the inner cavity can be achieved by
reconstitution of membrane proteins in the block copolymer membrane. Most of
the channel proteins are size selective, e.g., OmpF (B), others are substrate speciﬁc,
e.g., Tsx (C). (With Copyright permission of Adv. Funct. Mater.).
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an unprecedented tailoring and engineering of membrane proper-
ties and interactions, based on the choice of polymer type, block ra-
tio and molecular weight [85]. To date, polymersomes have been
assembled from diverse di- and triblock copolymers [86]. Even
bio-inspired building blocks such as various peptide residues and
polysaccharides can be employed successfully to tune membrane
formation [87–94]. Zwitterionic- [95], sensor-responsive [96,97]
and stimuli-responsive building blocks have been used to prepare
membranes with desired properties. For biomedical applications
from polymers towards bio-polymeric hybrid structures with spe-
ciﬁc functionalities and biocompatibility are to be developed [98–
100].
Important parameters such as the membrane thickness of a
polymersome depend on the chemical nature, the chain length of
the polymer blocks, the hydrophobic/hydrophilic ratio, the experi-
mental conditions and the molecular weights of the polymers
[101]. Polymersomes also have signiﬁcantly lower critical aggrega-
tion concentrations; once assembled they generally remain in a
stable architecture, except for drastic perturbation. In contrast to
phospholipids which are a subject of oxidation, polymersomes
may be assembled from relatively stable materials and can have
signiﬁcantly longer shelf lives [98,102]. Therefore, it is reasonable
that an increasing attention is being paid to the exploitation of
polymersomes in therapeutics, namely as candidates for drugs
[94,103–106] DNA [107] and protein delivery purposes [108,109].
Now, a research is directed to the design of polymer vesicles
that allow for the entrapment of RNA [4] and for the simultaneous
loading of hydrophilic and hydrophobic drugs with high efﬁciency
[103]. Moreover, smart polymersomes that respond to internal or
external stimuli such as temperature, pH, oxidative stress, light,
magnetic ﬁelds and ultrasound have been extensively studied dur-
ing the last few years [106,110–113]. This responsiveness is of a
high interest for the drug delivery ﬁeld as it enables to precisely
control the time and site (diseased place) of drug release. Most of-
ten, the vesicle membrane responds to external or internal trigger
by changing its permeability or even by changing the whole mor-
phology [110].
For efﬁcient therapeutic applications, another key point is the
targeting of speciﬁc sites, such as diseased cells or tissue, by an ac-
tive receptor–ligand mechanism [114]. Principally, targeting can
be achieved by functionalization of the membrane surface via
introducing biological ligands such as sugars, aptamers, peptides
and proteins, vitamins and antibodies [115]. In a similar manner,
polymersomes can be speciﬁcally immobilized to solid substrates
and surfaces, which is decisive for sensors and for surface modiﬁ-
cations applications [110,116,117].
Taken together, polymersomes open new perspectives for diag-
nostic and theranostic applications [118–120] serving as a plat-
form for combination of bioactive compounds with detection
agents such as ﬂuorescent dyes [121,122], inorganic compounds,
or metal complexes [123–128]. Encapsulation inside polymer-
somes represents a promising way to prevent side and toxic effects
of active compounds such as quantum dots or MRI contrast agents.
Various applications of block copolymer membranes are described
in a range of reviews that provide a good overview of the current
state of the art [4122,129]. In the following, we will show that
polymersomes and polymer-based matrices are challenging plat-
form to develop novel contexts in synthetic biology.
3. Polymersomes as enzymatic nanoreactors
One of the most important processes deﬁning a cell as ‘‘living’’
is its metabolic activity. On the most basic level a metabolic pro-
cess can be reproduced by performing a single enzyme reaction in
a single compartment. Several examples demonstrate howpolymersomes have been turned into nanoreactors by encapsula-
tion of active enzymes. The polymersome functions as a protec-
tive cage, i.e. shielding in the enzymes while substrate and
products must diffuse in and out of the cage. Membrane perme-
ability is an important feature for nanoreactor efﬁciency as it
deﬁnes the access of medium solutes to the encapsulated
enzymes. The solutes diffusion depends on their own characteris-
tics (charge, weight) as well as on the membrane properties (e.g.
glass transition temperature, rigid rods, triblocks) and is, there-
fore, membrane speciﬁc. Several polymersomes are permeable
to a limited numbers of small molecules. Thus, for instance, the
membrane of poly(2-methyloxazoline)-b-poly(dimethylsiloxane)-
b-poly(2-methyloxazoline) (PMOXA-PDMS-PMOXA) vesicles
showed permeability to superoxide ions (O2 ) and the vesicles
were designed to function as antioxidant nanoreactors [130,131]
Whereas porous poly(styrene)-block-poly[L-isocyanoalanine(2-thi-
phen-3-yl-etyl)amide] (PS-b-PIAT) polymersomes were used to
encapsulate the Candida antarctica lipase B (CalB) [132,133].
However, the shells of most polymersomes turn out to be
impermeable to small molecules. The lack of permeability is a cru-
cial drawback for polymersomes, designed to function as nanore-
actors. This problem has been circumvented by reconstitution of
functional membrane proteins in the polymersome shell, which
enables tuning of the membrane diffusion for most substrates
(Fig. 3).
The concept of reconstitution of puriﬁed membrane proteins
into polymersomes was introduced by Meier and co-workers in
2000 [134] and has been widely explored since then for diverse
biomedical and/or biotechnological applications [135]. Several
channel proteins such as Aquaporin Z (AqpZ) [136] and diverse
bacterial membrane proteins [137,138] have been incorporated
in polymersome membranes. Even more complex membrane pro-
teins, such as NADH/ubiquinone oxidoreductase (Complex I) [139]
and Bacteriorhodopsin (BR) in combination with ATPase [140] have
been embedded in polymer vesicles facilitating the transport of
ions into the polymersomal lumen. In the recent years, research
has progressed toward increasing the complexity of a nanoreactor.
This has been achieved by implementing of cascade enzymatic
reactions in a single polymersome, where enzymes work together
in a tandem for the conversion of a substrate. One of the ﬁrst exam-
ples of a complex biocatalytic process performed in a polymersome
nanoreactor is reported by Choi and Montemagno [140]. The
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PDMS-block-poly(2-ethyl-2-oxazoline) (PEtOz-PDMS-PEtOz) poly-
mersomes some of the cellular machinery for the biosynthesis of
ATP, namely F0F1-ATP synthase and bacteriorhodopsin (BR)
(Fig. 4). Only polymersomes that reconstitute both membrane pro-
teins were able to produce ATP, demonstrating the feasibility of
performing biosynthesis in polymersomes and their potential as
artiﬁcial organelles, respectively [141–143]. A recent major ad-
vance in the development of compartmentalized vesicles was the
production of a vesicle with two distinct interior compartments
[144,145]. This can be achieved through ﬁrst forming the compart-
ment vesicles and subsequently forming the larger polymersome-
based structures in the presence of the compartment vesicles
[146]. Mechanical robustness combined with the potential for
membrane protein insertion are valuable features for new ap-
proaches in drug discovery [147]. The progression of microﬂuidic
techniques will enable further compartmentalization in polymer-
somes which might facilitate the reproduction of metabolic reac-
tions, respectively.
Two-step cascade reactions have been also established by incor-
porating two different enzymatic species in LbL capsules. It was
shown to be possible to create an organelle inside an organelle,
both of which were functionalized with different enzymes. Com-
partmentalization is an essential element for recreating the func-
tions of cell organelles.
A fascinating example for creation of monofunctional organelle
prototype, though not implemented as a ‘‘real’’ nanoreactor, is the
DNA-loading device constructed by Graff et al. [143]. The pre-
served functionality of LamB, a maltose binding protein on bacte-
rial surfaces, ‘‘immersed’’ in an artiﬁcial, polymeric membrane
environment, is remarkable since it effectively dupes a phage intoFig. 4. Schematic overview of the ATP synthetic system reconstituted with both bacterior
Copyright 2005.recognizing a synthetic polymer vesicle as though it was a cell
(Fig. 5).
Remarkably, the activity of the encapsulated enzymes can be
regulated by a particular trigger that can be an external stimulus
(e.g. pH, temperature, reducing agent, light) or change in the local
environment. By engineering channel proteins genetically and
chemically, pores can be designed to respond to a wider variety
of external stimuli, thus enhancing the control of permeability
[138]. Several attempts in this direction are underway, although
not all of these studies were carried out with Polymersomes, but
with polyelectrolytes, hydrogels and carbohydrate-based struc-
tures [100,103,148] (see Fig. 6).
The above-cited studies on the selective and gated permeability
of lipid and block copolymer membranes are focused on protein-
based nanopores. An increasing attention has been paid to solid-
state nanopores [149] and an artiﬁcial nuclear pore complexes.
These are synthetic nanopores designed to mimic natural nanop-
ores, but also to circumvent their limited stability in a lipid bilayer.
Currently, of a special interest are the chemical modiﬁcations to
such nanopores, offering greater discrimination between anions
or cations, for example, or increased selectivity for DNA of certain
lengths [150]. While the synthetic nanopores possess very good
stability, they still do not offer the ﬂexibility of accomplishing
chemical modiﬁcation with atomic precision, achievable with pro-
tein pores [151].
4. Membrane proteins in polymeric structures
Alternatively, to the above mentioned role of membrane pro-
teins as ‘‘gate keepers’’ for membrane transport (employed in arti-
ﬁcial polymeric membranes), in nature, membrane proteins are anhodopsin (BR) and F0F1-ATP synthase. (Reproduced with permission from ACS [140]
Fig. 5. PMOXA-b-PDMS-b-PMOXA vesicle loaded with DNA. The k-phage binds to a reconstituted, maltose binding protein, LamB, afterwards, the phage transfers the DNA
cargo across the block copolymer membrane. The electron micrograph image shows negatively stained complexes formed between k phage and vesicles bearing LamB
protein. Adapted with permission. Copyright 2002, National Academy of Sciences, USA.
Fig. 6. Schematic draw of a membrane protein, inserted into a planar membrane structure by ‘‘direct’’ synthesis via in vitro strategy. Ligand binding shall still be possible as
indication for physiological structure, however, the embedding matrix can be comprised of phospholipids (left) as well as amphiphilic block-copolymers (right).
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amphiphilic entities with subtle structure–function dependencies.
They are highly regulated in the biochemical pathway of a cell and
execute life-essential functions. Addressing membrane proteins
in vitro or in vivo is a well-known difﬁculty, since they are notori-
ously complex to synthesize, isolate and handle. Upon insertion of
membrane proteins in an artiﬁcal membrane architecture (regard-
less of being a planar, lipid or polymer-based) if the membrane
protein is embedded in a random orientation its structural infor-
mation is lost. At present, this ‘‘loss in insertion direction’’ is a ma-jor drawback in the ﬁeld of membrane protein analysis, a
drawback, which complicates the membrane protein expression,
isolation and reconstitution. A successful approach for ‘‘guiding’’
isolated and detergent solubilized membrane protein molecules
into a membrane architecture was achieved by Meier and co-work-
ers. They were able to direct the orientation of Aquaporin mole-
cules in a polymer membrane, mimicking the asymmetry of a
natural lipid membrane by controlling the block copolymers archi-
tecture [152]. The use of polymers as lipid-analogs is a relatively
new approach and has, as such, not been applied to many different
Fig. 7. Hypothesis about how the in vitro synthesis of membrane proteins in vicinity of a planar membrane matrix works. The cell-free extract is harvested from bacterial,
plant or mammalian cells, depleted from endogenous genetic materials but still with acting protein synthesis. The genetic material, coding for an interesting membrane
protein is provided by pipetting into this ﬂuid and, with temperature control, the protein synthesis is taking place. Afterwards, the surface is rinsed and the resp. protein is
characterized, for example by electrochemical or immunological methods.
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the lateral mobility of polymer-embedded proteins has been sub-
stantially decreased– this phenomenon can be addressed by fur-
ther adaptation of the block copolymers. Additionally, toxicity
and biodegradability will be important issues in the progress of
polymer-based membrane mimicks.
In parallel, novel approaches to synthesize and insert mem-
brane proteins in membrane architectures are explored. Mem-
brane proteins had been generated in cell culture and isolated by
detergent solubilization from the native membrane context.
Reconstitution in phospholipid membranes as well as in polymeric
membrane architectures had been described. Recently, cell-free
strategies are underway, where the machinery of a cell is employed
to transcribe and translate a protein of interest from the coding
DNA. At this point, we like to refer to the comprehensive review
of Federico Katzen et al. about the cell-free synthesis of membrane
proteins into polymeric architectures [153]. It is quite foreseeable,
that the concept of cell-free, or so called in vitro synthesis ofproteins, is an inspiration to synthetic biology for enabling the
combination between complex protein structures and synthetic
materials and architectures. Block-copolymer membranes, which
mimic the cellular lipid membranes can be functionalized with
in vitro synthesized proteins as if those structures are native endo-
plasmic membranes (see Fig. 7).
Novel approaches and strategies for cell-free protein synthesis
are described recently [154,155], and it is well perceived, that
these will enable, most likely, the protein synthesis in artiﬁcial
membranes.
5. Artiﬁcial organelles based on polymeric architectures
A strategy to address the topic of ‘‘artiﬁcial organelles’’, is to
integrate a polymersome-based nanoreactors into living cells
[156,157]. For ﬁrst time this has been achieved by Meier and
coworkers [158,159]. In a very intelligent manner they functional-
ized the outer surface of trypsin-loaded PMOXA-PDMS-PMOXA
Fig. 8. Schematic representation of polymeric nanoreactors as artiﬁcial organelles: (a) polymeric nanoreactors, (b) schematic representation of a cell, (c) transmission
electron micrograph of intracellular nanoreactors, (d) Microscopic-image of macrophage cells containing nanoreactors (reprinted with permission from P. Tanner et al. [157]
FEBS Letters.
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that is recognized by certain macrophages and triggers internaliza-
tion. Internalization was detected speciﬁcally in macrophages,
whereas other cell types did not show signiﬁcant cell uptake.
Furthermore, the group of Meier integrated PMOXA-PDMS-
PMOXA nanocontainers into cells, where the polymersomes be-
haved as artiﬁcial organelles able to detect and combat superoxide
radicals effectively [122]. The polymer-embedded enzyme moie-
ties were shown to work in tandem in the nanovesicle cavity,
transforming superoxide radicals to molecular oxygen and water
and, therefore, mimicking their natural behavior. A channel pro-
tein, an outer membrane protein, facilitates the diffusion of lacto-
peroxidase substrate/products and dramatically increased the
penetration of superoxide radicals through the polymer mem-
brane, as established by activity assays [160] (Fig. 8).
Another example demonstrating that a polymer-based artiﬁcial
organelle is capable of neutralizing oxidative species in a cellular
environment is the work of van Dongen et al. [156]. To induce
cellular uptake by a human cell line, the researches decorated
the surface of the respective polymersomes with a peptide, known
to penetrate a cellular membrane. His group demonstrated the suc-
cess of the functional–structural integrity of the containers inside
the living cells by an enzymatic assay.
Taken together, the ﬁeld of artiﬁcial organelles is emerging.
Still, more examples need to be established; however, most poly-
meric man-made materials made are alien to the biological context
and need to be viewed under the perspective of biocompatibility
and degradability, respectively.
6. Conclusion and outlook
Synthetic biology is a mere description of a ﬁeld, which still
needs to be ﬁlled with content. As a consequence from System
Biology, it shall not be underestimated by its potential, rather rec-
ognized as an umbrella, hosting established ﬁelds as well as novel
ideas.
The common denominator in synthetic biology is its interdisci-
plinary character and the link towards the engineering and mate-
rial based-sciences. We would like to present synthetic materials
and architectures to be a relevant aspect of synthetic biology.
Polymersomes with embedded membrane proteins turned to beattractive model systems. Evidently, due to their robustness, struc-
tural similarity to liposomes and diverse polymer functionality,
these structures should be able to support multiple features and
when introduced into living cells even be able to selectively inﬂu-
ence their metabolic pathways, or impart them with unnatural
activity.
Albeit recent advances in developing artiﬁcial organelles and
cell-mimetic systems from the bottom up approach, the ﬁeld is still
in its conceptual phase. Apparently, there is a plenty of room for
new developments. For instance, gene expression, protein synthe-
sis, inter-particle communication, particle compartmentalization
and self-replication remain a challenge and will be primary goals
of the forthcoming research. Of course, this entirely synthetic, bot-
tom-up approach will require many obstacles to be taken and it
seems to be less straightforward than the top-down approach,
which is focused, for example, on the construction of a synthetic
genome. Fortunately, the bottom-up approach does not constrain
the researchers to work only with biological building blocks, as is
the case of the top-down synthetic cell approach. Moreover, with
the contribution of polymer science, smart materials with con-
trolled behavior could be thought of. None of the established disci-
plines will be able to address questions of this complexity and, as
such, synthetic biology is prone to initiate and perform in interdis-
ciplinary interactions and collaborations. Certainly, the future
research of synthetic biology is about implementation of materials
and architectures into living matters, in view of increasing robust-
ness, but in parallel to understand the underlying concepts of life.
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